Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.
about
Cost benefit analysis of Haemophilus influenzae type b vaccination programme in IsraelHepatitis B vaccine by intradermal route in non responder patients: an update.Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).Hepatitis B vaccination in chronic kidney disease: review of evidence in non-dialyzed patients.Cost-effectiveness analysis of prophylactic lamivudine use in preventing vertical transmission of hepatitis B virus infection.Sensitivity analysis in economic evaluation: a review of published studies.
P2860
Cost-benefit analysis of a nationwide neonatal inoculation programme against hepatitis B in an area of intermediate endemicity.
description
1992 nî lūn-bûn
@nan
1992 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Cost-benefit analysis of a nat ...... ea of intermediate endemicity.
@ast
Cost-benefit analysis of a nat ...... ea of intermediate endemicity.
@en
type
label
Cost-benefit analysis of a nat ...... ea of intermediate endemicity.
@ast
Cost-benefit analysis of a nat ...... ea of intermediate endemicity.
@en
prefLabel
Cost-benefit analysis of a nat ...... ea of intermediate endemicity.
@ast
Cost-benefit analysis of a nat ...... ea of intermediate endemicity.
@en
P2860
P356
P1476
Cost-benefit analysis of a nat ...... ea of intermediate endemicity.
@en
P2093
Ginsberg GM
P2860
P304
P356
10.1136/JECH.46.6.587
P577
1992-12-01T00:00:00Z